As of Oct 21
| +0.10 / +2.60%|
The 5 analysts offering 12-month price forecasts for Sangamo BioSciences Inc have a median target of 13.00, with a high estimate of 30.00 and a low estimate of 8.00. The median estimate represents a +229.11% increase from the last price of 3.95.
The current consensus among 7 polled investment analysts is to Buy stock in Sangamo BioSciences Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.